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Abstract 
Purposing: The Central Sensitization Inventory (CSI) is a new patient‑reported instrument, which measures symp‑
toms related to Central Sensitivity Syndromes and Central Sensitization. The aim of this study was to translate the 
CSI into Spanish, and then to perform a psychometric validation, including a factor analysis to reveal the underlying 
structure.
Methods: In this two‑stage psychometric study participated 395 subjects with various chronic pain conditions and 
that were recruited from two Primary Care Centres. The CSI was cross‑culturally adapted to Spanish through double 
forward and backward translations. The psychometric properties were then evaluated with analyses of construct 
validity, factor structure and internal consistency. One subgroup (n = 45) determined test‑retest reliability at 7 days.
Results: The Spanish Version of CSI demonstrated high internal consistency (α = 0.872) and test‑retest reliability 
(r = 0.91). Factor structure was one‑dimensional and supported construct validity.
Conclusions: The psychometric properties of the Spanish version were found to be strong, with high test‑retest 
reliability and internal consistency, with similar psychometric properties to the English language version. Unlike the 
English version, however, a one factor solution was found to be a best fit for the Spanish version.
Keywords: Central Sensitization Inventory (CSI), Central sensitization, Central sensitivity syndrome, Chronic pain, 
Psychometrics, Spanish
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Background
Patient-reported outcome (PRO) measures (Garratt 
2009) are commonly used to assess a patient’s symptoms 
or functional status. Although PRO are subjective, it can 
help clinicians better understand how a condition influ-
ences a patient’s capabilities or symptoms (Fayers and 
Machin 2013). Physical symptoms are often unexplained 
by a specific organic cause. In fact, no organic explana-
tion can be found in 10 % of patients who report persist-
ing physical symptoms (Rief et  al. 2001). Furthermore, 
multiple somatic symptom occurrence is associated with 
higher rates of psychopathology and predict poorer treat-
ment outcomes (Lydiard et  al. 1993; Ahles et  al. 1991). 
The phenomenon of central sensitization (CS) has been 
proposed to explain some incidents of “non-organic” 
symptoms. CS involves an abnormal increase of pain 
caused by neuronal hyperexcitability and dysfunction in 
descending and ascending pathways in the central nerv-
ous system (Kindler et  al. 2011; Heinricher et  al. 2009). 
Central sensitivity syndrome (CSS) is a proposed cate-
gory of interrelated disorders, with a common etiology of 
CS (Kindler et al. 2011; Heinricher et al. 2009; Tracey and 
Dunckley 2004; Yunus 2000). Its family includes fibro-
myalgia, chronic fatigue syndrome, irritable bowel syn-
drome, temporomandibular joint disorder, and migraine/
tension–type headache (Kindler et  al. 2011; Heinricher 
et al. 2009; Tracey and Dunckley 2004; Yunus 2007).
The Central Sensitization Inventory (CSI) was designed 
as a tool to identify when a patient’s symptoms may be 
related to CS/CSSs (Neblett et  al. 2015). Their identi-
fication ensures the most appropriate treatment, and 
may prevent inappropriate diagnostic testing. Part A of 
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the CSI assesses 25 health-related symptoms common 
to CSSs, with total scores ranging from 0 to 100. Part 
B (which is not scored) asks if one has previously been 
diagnosed with one or more specific disorders, includ-
ing seven separate CSSs. The original English version of 
the CSI was initially validated, having good psychometric 
properties (Neblett et al. 2015). Subsequent studies have 
found the CSI to be highly associated with the presence 
of CSS diagnoses in chronic pain patients (Neblett et al. 
2013, 2015; Mayer et al. 2012). A score of “40” has been 
proposed as a cut-off score (Neblett et  al. 2013, 2015; 
Mayer et  al. 2012). More recently, CSI severity ranges 
have been proposed (Neblett et al. 2016).
Translations and validation studies of the CSI have 
been completed, or are currently proceeding, in a num-
ber of different languages, including Dutch (Kregel et al. 
2015), French (Pitance et  al. 2016) and others (personal 
communication). Therefore, the aim of the current study 
was to translate the CSI into European-style Spanish 
(CSI-Sp), and to subsequently validate the psychometric 
properties.
Methods
A two-stage psychometric study was conducted. First, 
an initial translation and cross-cultural adaptation of the 
CSI, from English to Spanish, was performed. Then, a 
physical therapy outpatient population was used for eval-
uation of the CSI-Sp’s critical psychometric properties. 
The translation into Spanish was aimed to ensure con-
ceptual equivalence of all of the test items, while main-
taining proper cultural linguistic qualities. As detailed in 
the literature, a direct- and reverse-translation methodol-
ogy was utilized by a specialist in the field (Cuesta-Vargas 
et al. 2010; Muñiz et al. 2013).
A total of 395 volunteers (54.4  ±  13.6  years, 55.6  % 
male) were recruited consecutively from the commu-
nity-based Physiotherapy Program at the Malaga Uni-
versity. Exclusion criteria were; Chronic musculoskeletal 
pain for less than 3  months; diagnosis of specific medi-
cal conditions that can negatively affect the central nerv-
ous system, including cancer, brain or spinal cord injury, 
neurological disease or injury; Aged <18  years old and 
Poor Spanish language comprehension. Diagnoses were 
made by a physician in two primary care centres in Tor-
remolinos, Malaga, Spanish National Health Service. All 
eligible participants completed the three Spanish lan-
guage versions of the self-administered questionnaire 
CSI-Sp.
Statistics
Descriptive analyses were applied to calculate means 
and standard deviations of demographic variables. Dis-
tribution and normality were determined by one-sample 
Kolmogorov–Smirnov tests (significance <0.05). Con-
struct validity and factor structure were determined 
through the use of questionnaire principal component 
analysis with Maximum Likelihood Extraction (MLE), 
with the requirements for extraction being the satisfac-
tion of all three points: screeplot inflection point, Eigen 
value >1.0 and accounting for >10 % of variance (Costello 
and Osborne 2005). The recommended minimum ratio 
of five participants-per-item was satisfied (Costello and 
Osborne 2005). Internal consistency of the scale items 
was determined from Cronbach’s α coefficients as calcu-
lated at an anticipated value range of 0.80–0.95 (Terwee 
et  al. 2007; Cronbach 1951). Reliability was performed 
using the Intraclass Correlation Coefficients Type 2,1 
(ICC2.1) test–retest methodology in a randomly selected 
subgroup of the full sample determined at 7 days (n = 45, 
49 ± 5.2 years, 51.1 % female).
An error range of 0 ± 10 % was allowed in determin-
ing the test–retest reliability. The MDC90 analysis was 
performed as described by Stratford (2004). The stand-
ard error of the measurement (SEM) was calculated 
using the formula: SEM  =  s√(1  −  r), where s  =  the 
mean and standard deviation (SD) of Time 1 and Time 
2; r = the reliability coefficient for the test and Pearson’s 
correlation coefficient between test and retest values. 
Thereafter, the MDC90 was calculated using the formula: 
MDC90  =  SEM  ×  √2  ×  1.96. All statistical analyses 
were conducted using the SPSS 21.0 for Windows. Ethi-
cal clearance was approved by the Tribunal of Review of 
Human Subjects at the University of Malaga.
Results
The demographic and frequency of diagnoses of the sam-
ple are detailed in Table  1. The Spanish version of CSI 
provided can be found in “Appendix”. The normative val-
ues from CSI-Sp score were 24.6  ±  12.0 points (mean, 
SD). CSI-sp score distribution is detailed in Table 2.
The CSI-Sp showed no missing responses and it 
showed a high degree of internal consistency (Cron-
bach’s α  =  0.872) with an individual item range from 
0.851 to 0.891. The test–retest reliability was high at 
(ICC2.1  =  0.91) with an individual range from 0.87 to 
0.95. Measurement error was determined from SEM 
and MDC90, being at 2.52 and 7.83  %, respectively. No 
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significance differences were found between genders in 
item responses.
The correlation matrix for the CSI-Sp was determined 
suitable from the Kaiser-Meyer-Oklin values (0.864) and 
Barlett’s Test of Sphericity (p  <  0.001). This indicated 
that the correlation matrix was unlikely to be an identity 
matrix and, therefore, was suitable for MLE. The factor 
analysis revealed a satisfactory percentage of total vari-
ance explained by the one factor at 25.9 %. However, the 
items with an Eigenvalue >1.0 each accounted for <10 % 
of variance and were shown to be after the screeplot 
initial inflection point and consequently not extracted. 
The screeplot (see Fig.  1) indicated a one-factor solu-
tion. The item loading for the one-factor solution for the 
MLE method and average score for each item is shown in 
Table 3. The Goodness-of-fit test revealed a Chi square of 
866.04 (p < 0.000).
Discussion
In the present study, a cross-cultural adaptation of the 
CSI, from English to the Spanish, was completed, result-
ing in a CSI-Sp version of this Inventory. Construct 
validity and internal consistency of the CSI-Sp were 
determined independently, and were both found to be 
strong. The single factor structure from this psychomet-
ric properties indicated that a single summated score 
could be used (Doward and McKenna 2004). The one-fac-
tor solution that emerged in the factor analysis accounted 
for a significant proportion of variance, and showed 
evidence supporting the presence of construct validity. 
The findings of the current study, however, is contrast 
with the English (Mayer et al. 2012), Dutch (Kregel et al. 
2015), and French (Pitance et al. 2016) versions. The first 
two versions revealed a 4-factor model, and the French 
version produced 5-factors. However these studies did 
not satisfy the three point requirements for extraction, 
as recommended by Costello and Osborne 2005 and in 
the other hand, our study shown a low variance explained 
(Costello and Osborne 2005). Both English and Dutch 
versions demonstrated 3 (Garratt 2009; Heinricher et al. 
2009; Costello and Osborne 2005; Terwee et al. 2007) or 
5 (Garratt 2009; Heinricher et al. 2009; Kregel et al. 2015; 
Stratford 2004) items with an insufficient load on any fac-
tor. A one-factor solution is critical if a PRO is used with 
a single summated score, and it subsequently reflects the 
construct for which it is primary employed—that of rep-
resentation of the only CS condition.
High test–retest reliability, was found (ICC  =  0.91), 
which was in-line with the test–retest results of the English 
(0.82) (Mayer et al. 2012), Dutch (0.88) (Kregel et al. 2015) 
and French versions (0.91–0.94) (Pitance et al. 2016). Con-
sequently, the current study shows that the CSI-Sp should 
prove to be a reliable instrument. Internal consistency 
Table 1 Anthropometric variables, CSI punctuation, most 
common diseases and diagnoses from CSI part B
Values expressed as mean (Standard Deviation) and percentage (n)
BMI Body Mass Index, CSI Central Sensitization Inventory, TJD 
temporomandibular joint disorder
n = 395
Avg age (SD) 55.07 (12.72)
Avg weight [(Kg) (SD)] 71.84 (14.05)
Avg height [(m) (SD)] 1.67 (0.09)
Avg BMI [(kg/m2) (SD)] 25.61 (4.16)
Gender
Men [% (n)] 55.6 % (219)
Women [% (n)] 44.4 % (176)
Low back pain [% (n)] 55.2 % (216)
Neck pain [% (n)] 34.3 % (134)
Back pain [% (n)] 11.5 % (45)
Knee pain [% (n)] 6.6 % (26)
Artrhosis [% (n)] 5.4 % (21)
Shoulder pain [% (n)] 4.6 % (18)
CSI part B
Restless leg syndrome [% (n)] 3.3 % (13)
Chronic fatigue syndrome [% (n)] 2.3 % (9)
Fibromyalgia [% (n)] 5.9 % (23)
TJD [% (n)] 6.4 % (25)
Migraine or tension headaches [% (n)] 11.8 % (46)
Irritable bowel syndrome [% (n)] 7.9 % (31)
Multiple chemical sensitivities [% (n)] 1 % (4)
Neck injury (including whiplash) [% (n)] 21 % (82)
Anxiety or panic attacks [% (n)] 11.8 % (46)
Depression [% (n)] 10.7 % (42)
Table 2 CSI-Sp score divided by punctuation <or> than 40 
points (%, n) and scores (mean, SD) divided by main diag-
nostics
Diagnosis CSI < 40 % (n) CSI > 40 % (n) CSI punctuation 
(mean, SD)
Low back pain 58.1 (165) 37.8 (14) 25.85 (11.21)
Neck pain 32.7 (93) 32.4 (12) 25.02 (10.25)
Back pain 12 (34) 13.5 (5) 23.80 (11.78)
Knee pain 6.3 (18) 8.1 (3) 24.42 (11.33)
Arthrosis 4.2 (12) 5.4 (2) 28.64 (15.82)
Shoulder pain 5.3 (15) 2.1 (7) 21.75 (10.14)
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analysis showed a level of 0.872, below the accepted 0.95 
thresholds for item redundancy (Terwee et al. 2007). Simi-
larities were found in the internal consistency of all 25 
items of the CSI in the original study of the English version 
(Cronbach’s α = 0.879) (Mayer et al. 2012) and the Dutch 
version (Kregel et al. 2015) (Cronbach’s α = 0.91).
This present translation proportionated accessibility 
to the CSI-Sp for the second largest geographically-used 
language (United Nations 2016) A cross-cultural adapta-
tion of a scale has been previously done to be applied in 
the Spanish context (Muñiz et  al. 2013). It is critical to 
employ valid and reliable research measures which are 
culturally and linguistically appropriated.
The strengths of the present study included its prospec-
tive nature and adequate number of subjects; the inclu-
sion of consecutive patients; and the limited selection 
bias (Kass and Tinsley 1979). Obtaining results support-
ing the psychometric properties of the previous research 
on the original English version indicates that may it be 
possible to compare Spanish and English population and 
that cross-cultural adaptions would be appropriate to 
other diverse linguistic groups.
One limitation of the present study is the lack of 
longitudinal data regarding other psychometric prop-
erties and not including Hispanic/Latino/South 
American participants, which would have potentially 
provided confirming or conflicting linguistic informa-
tion. Hence, it would be appropriate to include them in 
futures studies. Other limitation was the sample size to 
run Confirmatory Factor Analysis focussing to identify 
the best factor structure, in this way we are started a 
pool of data (n > 2000) across the different countries/
languages (US, Spain, Belgium, France, Serbia, Italy 
and Brazil).
Conclusions
The psychometric properties of the CSI-Sp are reported 
for the first time. The determined values were satisfactory 
and supportive of the validation of the CSI-Sp, particu-
larly in the areas of internal consistency, factor structure 
and reliability. Consequently, the CSI-Sp may be useful 
in Spanish-speaking populations and for making cross-
cultural comparisons in other English-speaking countries 
with a high Spanish-speaking population.
Fig. 1 Scree plot indicating one factor solution
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Me siento cansado y desanimado cuando me levanto por las 
mañanas
0.612
Mis músculos están tensos y doloridos 0.650
Tengo ataques de pánico 0.388
Rechino los dientes o aprieto la mandíbula 0.342
Tengo problemas de diarrea o estreñimiento 0.400
Necesito ayuda pare realizar mis actividades diarias 0.476
Soy sensible a la luz brillante 0.440
Me canso fácilmente cuando estoy físicamente activo 0.724
Siento dolor en todo mi cuerpo 0.582
Tengo dolores de cabeza 416
Tengo molestia en mi vejiga o sensación de quemazón al orinar 0.294
No duermo bien 0.504
Tengo dificultad para concentrarme 0.436
Tengo problemas en la piel como resequedad, picor o sarpullido 0.299
El estrés hace que mis síntomas físicos empeoren 0.587
Me siento triste o deprimido 0.621
Me siento con poca energía 0.718
Tengo tensión muscular en mi cuello y hombros 0.555
Tengo dolor en mi mandíbula 0.426
Algunos olores, como perfumes, me hacen sentir náuseas. 0.269
Tengo que orinar frecuentemente 0.276
Mis piernas se sienten incómodas e inquietas cuando intento 
dormir por la noche
0.476
Tengo dificultad para recordar cosas 0.482
Sufrí algún trauma cuando era niño (a) 0.120
Tengo dolor en mi zona pélvica 0.289
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Appendix
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre
Nunca Pocas Veces Algunas veces Continuamente Siempre




Nombre:                                                                              Fecha:
Por favor rodee la respuesta correcta para cada uno de los enunciados.
1.   Me siento cansado y desanimado cuando me levanto por las  mañanas.
2.   Mis músculos están tensos y doloridos.
3.   Tengo ataques de pánico.
4.   Rechino los dientes o aprieto la mandíbula.
5.   Tengo problemas de diarrea o estreñimiento.
6.   Necesito ayuda pare realizar mis actividades diarias.
7.   Soy sensible a la luz brillante.
8.   Me canso fácilmente cuando estoy físicamente activo.
9.   Siento dolor en todo mi cuerpo.
10. Tengo dolores de cabeza.
11. Tengo molestia en mi vejiga o sensación de quemazón al orinar.
12. No duermo bien.
13. Tengo dificultad para concentrarme.
14. Tengo problemas en la piel como resequedad, picor o
sarpullido.
15. El estrés hace que mis síntomas físicos empeoren.
16. Me siento triste o deprimido.
17. Me siento con poca energía.
18. Tengo tensión muscular en mi cuello y hombros.
19. Tengo dolor en mi mandíbula.
20. Algunos olores, como perfumes, me hacen sentir mareado y 
con náuseas.
21. Tengo que orinar frecuentemente.
22. Mis piernas se sienten incómodas e inquietas cuando intento 
dormir por la noche.
23. Tengo dificultad para recordar cosas.
24. Sufrí algún trauma cuando era niño(a).
25. Tengo dolor en mi zona pélvica
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NO SÍ Año del
diagnóstico
Parte B
Nombre:                                                                         Fecha:
¿Ha sido usted diagnosticado por algún m é d i c o con alguna de las
siguientes enfermedades?
Por favor indique a la derecha de cada casilla si ha tenido alguno de los
siguientes diagnósticos y escriba el año en que se le diagnosticó.
1. Síndrome de Piernas Inquietas.
2.  Síndrome de Fatiga Crónica.
3.  Fibromialgia.
4.  Trastornos Temporomandibulares.
5.  Migrañas o Cefalea Tensional.
6.  Síndrome de Colon Irritable.
7.  Sensibilidad Química Múltiple.
8.  Latigazo o Lesión en el Cuello (incluir la lesión de Whiplash).
9.  Ansiedad o Ataques de Pánico.
10. Depresión.
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